Credit Suisse Ag Vista Gen Therapeutics, Inc. Transaction History

Credit Suisse Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.09 - $4.8 $203 - $10,833	-2,257 Reduced 99.65%	8 $0
Q3 2022 Nov 10, 2022	BUY	$0.14 - $4.8 $303 - $10,401	2,167 Added 2211.22%	2,265 $0
Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.73 $86 - $169	98 New	98 $0

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.